Neuromuscular Disorders clinical trials

Explore recruiting neuromuscular disorders clinical trials.

Recruiting neuromuscular disorders studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neuromuscular Disorders trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I/II, open-label, dose escalation study to evaluate the safety of 2 doses of intravenous ATA-200, an adeno-associated viral vector carrying the human gamma-sarcoglycan gene, in patients with gamma-sarcoglycanopathy (limb-girdle muscular dystrophy LGMDR5, formerly LGMD2C).

France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

ASPIRO: A Phase 1/2/3, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular Myopathy (XLMTM) Patients

Germany, France

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 1b study to investigate safety and tolerability of ARGX-119 in adult participants with DOK7 Congenital Myasthenic Syndrome (CMS)

Spain, Austria, Italy, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An Open-Label Study of Risdiplam in Infants with Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy

Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen - ONWARD

Italy, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer 18F-AlF-FAPI-74 versus standard of care 18F-FDG in inflammatory disorders.

Belgium

Phase II and Phase III (Integrated) EU CTIS Study details

Neuromuscular Disorders trials by city

Neuromuscular Disorders clinical trials

Recruiting neuromuscular disorders studies right now

Y-4 to Treat the Postherpetic Neuralgia

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus

Instrument-Assisted Soft Tissue Mobilization Versus PNF Stretching in Athletes With Piriformis Syndrome

Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis

Regime for Vitamin D Maintenance in Post-Operative Patients

Respiratory Muscles and Work of Breathing in Children

Magnesium and Cramping

Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)